PDCD4 and major depressive disorder: To mimic the effect of mTORC1 activity changes in depression in vivo, HT-22 and BV2 were treated with mTORC1 inhibitor rapamycin (200 nM), and then the changes of Pdcd4 and BDNF expression were measured by western blot and ELISA.